(Q45751051)

15 December 2017

title

Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase (English)

1 reference

15 December 2017

Human T-lymphotropic virus 1

main subject

1 reference

1 reference

3

1 reference

15 December 2017

author name string

Louis JM

series ordinal

1

1 reference

15 December 2017

Oroszlan S

series ordinal

2

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

15 December 2017

Journal of Biological Chemistry

published in

1 reference

15 December 2017

volume

274

1 reference

15 December 2017

issue

10

1 reference

15 December 2017

page(s)

6660-6666

1 reference

15 December 2017

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

HTLV-I associated myelopathy, a new clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

21 January 2018

HIV-Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Expression of human T-cell leukemia virus type I protease in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Structure-based inhibitors of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Rational design of peptide-based HIV proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

HIV-1 proteinase is required for synthesis of pro-viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

The determination of enzyme inhibitor constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Subsite preferences of retroviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Structural Basis for Specificity of Retroviral Proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

Specificity studies on retroviral proteinase from myeloblastosis-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.10.6660

21 January 2018

Identifiers

DOI

10.1074/JBC.274.10.6660

1 reference

15 December 2017

1 reference

15 December 2017